A Case Study of Dexmedetomidine as an Intrathecal Adjuvant for Postoperative Analgesia in Orthopedic Lower Limb Surgeries
Abstract: BACKGROUND AND OBJECTIVE Spinal anaesthesia is the most common approach which is used for lower limb surgery. Dexmedetomidine is the recent drug which acts on 2-adrenergic receptors in the dorsal horn of the spinal cord to produce analgesic effects. The aim is to check efficacy and safety of intrathecal Dexmedetomidine added to Ropivacaine. Postoperative cumulative analgesic consumption and maximum visual analogue scale (VAS) pain score have been evaluated as secondary outcome. MATERIALS AND METHODS With simple random sampling technique, 60 patients of either sex between age group of 18 to 60 yrs, ASA I or II, posted for lower limb orthopedic surgery under spinal anaesthesia were selected who fulfil the inclusion, exclusion criteria and divided them into two groups of 30 each. RESULTS Both absolute and effective analgesia durations were prolonged in Group RD with absolute analgesia duration being 350.3359.49 minutes in Group RD as compared to 215.0325.57 minutes in Group R (p
Keywords: Dexmedetomidine, Ropivacaine, intrathecal, lower limb orthopedic, postoperative analgesia
How to Cite?: Dr. Athyun.G, Dr. Malathi.C.N, Dr. Nalini Kotekar, "A Case Study of Dexmedetomidine as an Intrathecal Adjuvant for Postoperative Analgesia in Orthopedic Lower Limb Surgeries", Volume 5 Issue 2, February 2016, International Journal of Science and Research (IJSR), Pages: 832-839, https://www.ijsr.net/getabstract.php?paperid=NOV161309, DOI: https://dx.doi.org/10.21275/NOV161309